Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2008
10/22/2008CN100427079C Vaginal foam preparation of chlorhexidine acetate and its preparing process
10/22/2008CN100427078C Decanoyl acetaldehyde compound and its medicinal composition
10/22/2008CN100427077C Dry powder inhalation system for transpulmonary administration
10/22/2008CN100427076C Medicinal preparation for treating embolus and its preparation method
10/22/2008CN100427075C Isatidis soft capsule and preparing method thereof
10/22/2008CN100427074C Medicine for treating fatty liver
10/22/2008CN100427073C Dripping pills made from black-bone chicken, and its prepn. method
10/22/2008CN100427072C Constipation relieving dripping pills with rhubarb and its preparation method
10/22/2008CN100427071C Cold treating dripping pills and its preparation method
10/22/2008CN100427070C Dripping pills for treating all kinds of rhinitis and its preparation method
10/22/2008CN100427069C Tongkening drip pill used for assistant treating of tumour and its preparation method
10/22/2008CN100427068C Kangai drip pill for treating tumour, hepatitis B and its preparation method
10/22/2008CN100427067C liver protection drip pill and its preparation method
10/22/2008CN100427066C Pharmaceutical preparation with functions of clearing heat, removing dampness and benefiting gallbladder
10/22/2008CN100427065C Tibetan medicinal preparation of dizziness, blood pressure irregulation and headache, and its preparing method
10/22/2008CN100427064C New method for preparing liposome
10/22/2008CN100427063C An wind-expelling ointment and method for preparing same
10/22/2008CN100427062C Tibetan medicine for major functions of acute-chronic sprain-contusion, rheumatism, rheumatoid diseases, and its preparing method
10/22/2008CN100426980C Oral veterinary drug delivery system and/or feed additive delivery system, process for the preparation and use thereof
10/21/2008US7439349 Method for preparation of large volume batches of poly-ICLC with increased biological potency; therapeutic, clinical and veterinary uses thereof
10/21/2008US7439269 application of moisturizer to nasal cavity may facilitate and/or promote healthy function of the cavity, which in turn may reduce the duration of symptoms associated with a common cold or the flu; comprising: purified water; a hydrophilic thickener; and an encapsulated moisturizing agent
10/21/2008US7439268 Compositions containing prodrugs of florfenicol and methods of use
10/21/2008US7439248 5-[[4-[3-Methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenyl-methyl]thiazolidine-2,4-dione or salt; compressed tablets; microcrystalline cellulose, magnesium stearate, lactose, or talc excipients; antidiabetic agents for non-insulin dependent diabetes; insulin sensitizers
10/21/2008US7439224 Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals
10/21/2008US7439044 High viscosity xanthan polymer preparations
10/21/2008US7438942 Applying syrup of maltitol, isomalt and binders
10/21/2008US7438930 Methylphenidate in a controlled release matrix coated with a hydrophobic acrylic polymer to retard release; enteric coating from an aqueous dispersion of an acrylic/methacrylic copolymer, a plasticizer and a glidant; topcoat of a second portion of the methylphenidate in immediate release form
10/21/2008US7438929 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
10/21/2008US7438928 Topical gel matrix
10/21/2008US7438927 Methods of treatment using a gastric retained gabapentin dosage
10/21/2008US7438926 Forming disruptions in stratum corneum layer of the skin to form pathways; causing the first agent and anti-healing agent to be fluxed through pathways for inhibiting a decrease in transdermal flux of a first agent
10/21/2008US7438925 Composed of therapeutic agent dispersed in modified, biologically active binders; agents used in coatings include paclitaxel, sirolimus; agents can be applied to surface of medical implant without using inert polymer carriers
10/21/2008US7438924 Dry granulated formulations of azithromycin
10/21/2008US7438903 Fine particle sizes; nanostructure; in mixture with oil, water carriers, excipients; oral diseases; cognition activators; hypotensive agents; immunology diseases; blood disorders
10/21/2008US7438722 Method for treatment of restenosis
10/21/2008US7438203 Dermal penetration enhancers and drug delivery systems involving same
10/21/2008CA2495327C Controlled release device and method using electrothermal ablation
10/21/2008CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
10/21/2008CA2412708C Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
10/21/2008CA2390284C Apparatus and method for preparing microparticles
10/21/2008CA2387383C Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
10/21/2008CA2359488C Inorganic shaped bodies and methods for their production and use
10/21/2008CA2351947C Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
10/21/2008CA2351484C Method of producing solid dosage forms
10/21/2008CA2341646C Method for producing solid dosing forms
10/21/2008CA2333648C Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
10/21/2008CA2293346C Device and method for treatment of dysmenorrhea
10/21/2008CA2282345C Pharmaceutical composition
10/21/2008CA2169071C Methods for modulating the human sexual response
10/21/2008CA2166108C Insulin preparations for inhalation
10/18/2008CA2583716A1 Oral dosage formulations of protease resistant polypeptides
10/16/2008WO2008124814A2 Sublingual formulations of d-cycloserine and methods of using same
10/16/2008WO2008124667A1 Cooling compositions including menthyl esters
10/16/2008WO2008124639A2 Poly (amino acid) targeting moieties
10/16/2008WO2008124634A1 Polymer-encapsulated reverse micelles
10/16/2008WO2008124632A1 Amphiphilic compound assisted nanoparticles for targeted delivery
10/16/2008WO2008124617A2 Rapidly dissolving pharmaceutical compositions comprising pullulan
10/16/2008WO2008124585A1 Lowering of proteins associated with alzheimer's disease by interrupting gene transcription with a small molecule
10/16/2008WO2008124165A2 Self-assembling nanoparticle drug delivery system
10/16/2008WO2008124126A1 Oxygen-generating compositions for enhancing cell and tissue survival in vivo
10/16/2008WO2008124081A2 Rapid dissolution of combination products
10/16/2008WO2008123797A1 Nanoemulsion with biologically active agents
10/16/2008WO2008123701A1 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
10/16/2008WO2008123536A1 Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
10/16/2008WO2008123471A1 Composition for cleaning nasal fossa
10/16/2008WO2008123396A1 Suspension-type eye drop preparation comprising fluorometholone
10/16/2008WO2008123298A1 Infusion preparation for cancer patient
10/16/2008WO2008122994A2 Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
10/16/2008WO2008122993A1 Controlled release formulation of coated microparticles
10/16/2008WO2008122967A2 An oral pharmaceutical composition
10/16/2008WO2008122966A2 A pharmaceutical composition of tacrolimus
10/16/2008WO2008122965A2 Pharmaceutical cyclosporin compositions
10/16/2008WO2008122638A2 Process for preparing pramipexole dihydrochloride tablets
10/16/2008WO2008122425A2 Oral compositions containing tacrolimus in amorphous form
10/16/2008WO2008122415A1 Stable aqueous g-csf formulations
10/16/2008WO2008122398A1 Biologically degradable multilayer system
10/16/2008WO2008122286A1 Center-filled chewing gum product for dental care
10/16/2008WO2008122192A1 Liposomal pharmaceutical carrier and process for preparation thereof
10/16/2008WO2008122190A1 The composition comprising l-carnitine or derivatives thereof and its use
10/16/2008WO2008122174A1 A chinese medicine preparation for treating and preventing diabetes and its complication, improving immunity and process thereof
10/16/2008WO2008122118A1 Pharmaceutical formulations of ghrh molecules
10/16/2008WO2008122104A1 Melatonin-based composition for improved sleep
10/16/2008WO2008122102A1 Melatonin-based composition for improved sleep
10/16/2008WO2008122101A1 Composition for promoting sleep and calmness comprising an extract of hops, eclipta alba and nordostachys jatamansi
10/16/2008WO2008122100A1 Composition for supporting restful sleep comprising valerian root extract and methylcobalamim
10/16/2008WO2008122085A1 Nanocomposites
10/16/2008WO2008102264A8 Stable digestive enzyme compositions
10/16/2008WO2008101173A3 Biodegradable compositions and materials
10/16/2008WO2008101098A3 Use of botulinum toxin and enzymes for treating bladder or prostata disorders, or hyperhydrosis
10/16/2008WO2008098245A3 Nmda receptor modulation and treatments for addictive behavior
10/16/2008WO2008097328A3 Asymmetric functionalized nanoparticles and methods of use
10/16/2008WO2008093358A3 Aqueous topical solution containing olopatadine
10/16/2008WO2008093221A3 Pharmaceutical compositions containing pde4 inhibitor for the treatment of inflammatory and allergic disorders
10/16/2008WO2008088882A3 Methods of generating cardiomyocytes
10/16/2008WO2008088776A3 Amorphous drug beads
10/16/2008WO2008086395A3 Anti-il-13 antibody formulations and uses thereof
10/16/2008WO2008085556A3 Surfactant-free nanoparticles for drug delivery
10/16/2008WO2008064259A3 Solid dispersion composition comprising fluvastatin
10/16/2008WO2008063562A3 Materials and methods of introducing genetic material into living cells
10/16/2008WO2008063341A3 Dual action, inhaled formulations providing both an immediate and sustained release profile